Total Payments
$1,393
2024 Payments
$336.05
Companies
21
Transactions
77
Medicare Patients
1,567
Medicare Billing
$85,459
Payment Breakdown by Category
Food & Beverage$1,393 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,393 | 77 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $300.38 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $224.94 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $121.39 | 8 | $0 (2024) |
| PFIZER INC. | $103.21 | 5 | $0 (2023) |
| Lilly USA, LLC | $90.52 | 6 | $0 (2024) |
| CSL Behring | $89.75 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $68.51 | 4 | $0 (2024) |
| Dexcom, Inc. | $56.57 | 3 | $0 (2024) |
| Corcept Therapeutics | $55.13 | 3 | $0 (2024) |
| ABBVIE INC. | $43.79 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $336.05 | 19 | GlaxoSmithKline, LLC. ($59.35) |
| 2023 | $270.38 | 13 | PFIZER INC. ($85.62) |
| 2022 | $432.14 | 25 | Novo Nordisk Inc ($131.42) |
| 2021 | $354.89 | 20 | Novo Nordisk Inc ($111.36) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Endocrinology | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Endocrinology | ||||||
| 10/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Gastroenterology | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Endocrinology | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Inflammation | ||||||
| 04/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Inflammation | ||||||
| 03/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Oncology | ||||||
| 02/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Diabetes | ||||||
| 01/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: WOMENS HEALTH | ||||||
| 10/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Diabetes | ||||||
| 09/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: GENETIC DISEASE | ||||||
| 09/11/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Endocrinology | ||||||
| 08/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 08/18/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 671 | 1,372 | $157,433 | $37,278 |
| 2022 | 10 | 356 | 573 | $58,212 | $15,835 |
| 2021 | 11 | 360 | 568 | $71,110 | $20,481 |
| 2020 | 7 | 180 | 236 | $41,342 | $11,865 |
Total Patients
1,567
Total Services
2,749
Medicare Billing
$85,459
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 325 | $72,865 | $16,471 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 103 | $32,668 | $6,628 | 20.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $14,880 | $4,821 | 32.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 40 | $10,496 | $2,512 | 23.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 34 | 43 | $2,795 | $1,576 | 56.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 28 | $4,564 | $1,114 | 24.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $1,960 | $1,007 | 51.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 72 | 84 | $2,100 | $705.60 | 33.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $2,042 | $659.25 | 32.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $901.00 | $490.79 | 54.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 68 | $3,604 | $476.06 | 13.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 13 | 15 | $675.00 | $243.00 | 36.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 23 | $759.00 | $211.19 | 27.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 232 | $4,176 | $172.53 | 4.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 41 | 67 | $536.00 | $147.40 | 27.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 23 | 106 | $1,252 | $35.72 | 2.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 21 | 116 | $1,160 | $8.17 | 0.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 160 | $26,400 | $7,562 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 86 | $20,210 | $5,364 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $4,080 | $1,703 | 41.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 30 | 52 | $2,756 | $446.25 | 16.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 18 | 18 | $702.00 | $264.06 | 37.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 66 | 74 | $1,850 | $219.87 | 11.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 16 | 20 | $660.00 | $191.79 | 29.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 23 | $184.00 | $51.32 | 27.9% |
About Sarah Sumner
Sarah Sumner is a Gerontology healthcare provider based in Cairo, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2019. The National Provider Identifier (NPI) number assigned to this provider is 1205398914.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Sumner has received a total of $1,393 in payments from pharmaceutical and medical device companies, with $336.05 received in 2024. These payments were reported across 77 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,393).
As a Medicare-enrolled provider, Sumner has provided services to 1,567 Medicare beneficiaries, totaling 2,749 services with total Medicare billing of $85,459. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Gerontology
- Location Cairo, GA
- Active Since 04/02/2019
- Last Updated 02/22/2022
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1205398914
Products in Payments
- TRELEGY ELLIPTA (Drug) $171.63
- Rybelsus (Drug) $145.08
- Ozempic (Drug) $137.13
- Haegarda (Biological) $89.75
- FARXIGA (Drug) $83.81
- XARELTO (Drug) $68.51
- Korlym (Drug) $55.13
- ELIQUIS (Drug) $47.96
- MOUNJARO (Drug) $45.20
- UBRELVY (Drug) $43.79
- Dexcom G6 Transmitter (Medical Supply) $41.18
- RUCONEST (Biological) $39.47
- PREMARIN (Drug) $37.66
- Otezla (Drug) $34.84
- SHINGRIX (Biological) $34.58
- TAKHZYRO (Biological) $31.69
- NURTEC ODT (Drug) $26.04
- BREZTRI (Drug) $24.27
- ANORO ELLIPTA (Drug) $18.73
- RYBELSUS (Drug) $18.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.